SCHEMBL4635558

SCHEMBL4635558

CCN(CC)N1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1269153 0.97 KDM4E (0.32)
SCHEMBL8718542 0.94
Hydrochloric Acid SCHEMBL23174550 0.91
SCHEMBL3985738 0.87
SCHEMBL4720625 0.84
SCHEMBL4231793 0.82 HRH3 (0.32)
SCHEMBL4765150 0.80 L3MBTL1 (0.32)
SCHEMBL16099104 0.80
SCHEMBL4721344 0.78 L3MBTL1 (0.34)
SCHEMBL7851389 0.77 SMN1; SMN2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109575045-A Thienopyrimidines, preparation method, Pharmaceutical composition and its application 南京红云生物科技有限公司 2019-04-05 CN claimed
WO-2008057420-A2 EXTENDED TRITERPENE DERIVATIVES PANACOS PHARMACEUTICALS, INC. (US) 2008-05-15 WO claimed
EP-1307429-B1 PROCESS FOR ASYMMETRIC SYNTHESIS OF SUBSTITUTED 1,4-DIHYDROPYRIDINES ASTRAZENECA AB (SE) 2007-11-28 EP claimed
US-7074931-B2 Process for asymmetric synthesis of substituted 1,4 -dihydropyridines ASTRAZENECA AB (SE) 2006-07-11 US claimed
US-20040039207-A1 Process for asymmetric synthesis of substituted 1,4 -dihydropyridines ASTRAZENECA AB (SE) 2004-02-26 US claimed
EP-1307429-A1 PROCESS FOR ASYMMETRIC SYNTHESIS OF SUBSTITUTED 1,4-DIHYDROPYRIDINES AstraZeneca AB (SE) 2003-05-07 EP claimed
WO-2002010134-A1 PROCESS FOR ASYMMETRIC SYNTHESIS OF SUBSTITUTED 1,4-DIHYDROPYRIDINES ASTRAZENECA AB (SE) 2002-02-07 WO claimed
US-10980816-B2 Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof SANOFI (FR) 2021-04-20 US disclosed
US-20200323874-A1 NOVEL THIENOPYRIMIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND THERAPEUTIC USES THEREOF SANOFI (FR) 2020-10-15 US disclosed
US-10736904-B2 Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof SANOFI (FR) 2020-08-11 US disclosed
US-20200078370-A1 NOVEL THIENOPYRIMIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND THERAPEUTIC USES THEREOF SANOFI (FR) 2020-03-12 US disclosed
US-20190151330-A1 NOVEL THIENOPYRIMIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND THERAPEUTIC USES THEREOF SANOFI (FR) 2019-05-23 US disclosed
CN-109575045-A Thienopyrimidines, preparation method, Pharmaceutical composition and its application 南京红云生物科技有限公司 2019-04-05 CN disclosed
US-7074931-B2 Process for asymmetric synthesis of substituted 1,4 -dihydropyridines ASTRAZENECA AB (SE) 2006-07-11 US disclosed
US-20040039207-A1 Process for asymmetric synthesis of substituted 1,4 -dihydropyridines ASTRAZENECA AB (SE) 2004-02-26 US disclosed
EP-1307429-A1 PROCESS FOR ASYMMETRIC SYNTHESIS OF SUBSTITUTED 1,4-DIHYDROPYRIDINES AstraZeneca AB (SE) 2003-05-07 EP disclosed
WO-2002010134-A1 PROCESS FOR ASYMMETRIC SYNTHESIS OF SUBSTITUTED 1,4-DIHYDROPYRIDINES ASTRAZENECA AB (SE) 2002-02-07 WO disclosed
EP-1152011-A1 PEPTIDES INHIBITING VASCULAR ENDOTHELIAL CELL MIGRATION KYOWA HAKKO KOGYO CO., LTD. (JP) 2001-11-07 EP disclosed
WO-1995015955-A1 2,4-DIAMINOTHIAZOLES AND THEIR PRODUCTION BASF AKTIENGESELLSCHAFT (DE) 1995-06-15 WO disclosed
US-5391819-A Process of making chiral 2-aryl-1,4-butanediamine derivatives as useful neurokinin-A antagonists MERCK & CO., INC. (US) 1995-02-21 US disclosed